marks@umdnj.edu
973-972-5892 (phone)
973-972-7440 (fax)

Speciality Areas:
Epilepsy; Functional MRI

Education:
University of Cape Town Medical School
Cape Town, South Africa, 7925.
Jan 1978-Dec 1983 MB.ChB. (6 years M.D. program)

Residency:
Resident in Neurology
7/85-6/88
Boston City Hospital
Boston, MA

Fellowships:
Neurophysiology Fellowship (EMG, EEG, EP, Sleep studies)
July 1988 - June 1989
Department of Neurology
New England Medical Center
Boston, Tufts Medical School
 
Epilepsy and Neurophysiology Fellowship
July 1988 - October 1991
Yale University Medical School
Emphasis on intensive seizure monitoring, medical and
surgical treatment of epilepsy

Research Interests:
Epilepsy and functional MRI

Research Support:

Double blind placebo controlled, parallel group study to assess the efficacy and safety of up to two doses of VML251 in the acute treatment of migraine. Vanguard Medica LTD.

Double blind placebo controlled, parallel group study to assess the efficacy of TOPAMAX (Topirimate) compared to Valproate as add-on therapy to carbamazepine with special emphasis on cognitive function in subjects with partial onset seizures. Ortho-McNeil Pharmaceutical.

Safety and efficacy of Gabifril (Tiagabine McL) monotherapy in the treatment of partial seizures Abbott Laboratories

Selected Publications:

Marks, DA, Kim J, Spencer DS, Spencer, SS. Seizure localization and pathology following head injury in uncontrolled epilepsy patients. In press Neurology 1995;45:2051-2057.

Tran TA, Spencer SS, Marks DA, Pacia S and Spencer DD. Significance of spikes recorded on electrocorticography in nonlesional medial temporal lobe epilepsy. Ann Neurol 1995;38:763-770.

Tran TA, Spencer SS, Pacia S, Marks DA and Spencer DD Significance of spikes recorded on intraoperative electrocorticography in patients with brain tumor and epilepsy. Epilepsia 1997;38:1132-1140.